Jeito Capital Leads $65M Series A to Advance Innovations in Reproductive Medicine
By Daniella Parra Jeito Capital said it led a $65 million Series A funding round...
Editorial
Navigating Market Volatility: ICR to Host Conference Spotlight Series Webinar Today, May 21
By Exec Edge Editorial Staff ICR, a global strategic communications and advisory firm, announced it...
Promontory Therapeutics Clears FDA Path to Phase 3 Trial for Advanced Prostate Cancer
By Daniella Parra Promontory Therapeutics said its Phase 2 meeting with the FDA cleared the...
ReAlta Life Sciences Presents COPD Treatment at ATS 2025
By Karen Roman ReAlta Life Sciences said it presented new clinical data from its Acute...
Grove Collaborative Updates 2025 Outlook, Focuses on Customer Experience
By Karen Roman Grove Collaborative Holdings, Inc. (NYSE: GROV) said total revenue was $43.5 million,...
Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin
By Daniella Parra Waldencast plc (Nasdaq: WALD) said net revenue decreased 4.1% year-over-year to $65.4...
a.k.a. Brands U.S. Net Sales Up 14.2%, Updates FY Guidance
By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said first quarter net sales grew...
Escape the Tariff Turmoil with Alliance Resource Partners – Exec Edge Research Initiation Report
Download the Complete Report Here By Rayk Riechmann As a leading natural resource firm based...
Jeito Capital Leads €132M Series to Advance Phase 3 Trials for Rare Neuro-Metabolic Disorders
By Daniella Parra Jeito Capital said it is leading a €132 million oversubscribed Series B...
On Q1 Net Sales Increase 43% as DTC Share Surges
By Daniella Parra On Holding AG (NYSE: ONON) said net sales increased 43% to CHF...
© Copyright 2025, ExecEdge